Strides Pharma Intl Drug Patent Portfolio
Strides Pharma Intl owns 1 orange book drug protected by 2 US patents Given below is the list of Strides Pharma Intl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5612367 | Method of enhancing bioavailability of pharmaceutical agents | 18 Mar, 2014 | Expired |
| US5482963 | Pharmaceutical agents useful as leukotriene antagonists | 09 Jan, 2013 | Expired |
Strides Pharma Intl's Family Patents
Recent FDA approvals and tentative approvals for Strides Pharma Intl
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Innovator drugs
Includes innovator drug submissions that appear in FDA approval and tentative approval disclosures.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Dolutegravir; Tenofovir Disoproxil Fumarate; Lamivudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | New Combination and New Formulation or New Manufacturer | 14 Sep, 2023 |
| Stavudine; Lamivudine; Efavirenz |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 01 Jun, 2007 |
| Stavudine; Lamivudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 13 Mar, 2007 |
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Lamivudine |
SUPPL-8
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Labeling | 14 Dec, 2016 |
| Tenofovir Disoproxil Fumarate |
SUPPL-6
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Labeling | 07 Dec, 2016 |
| Rilpivirine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 29 Sep, 2015 |
Strides Pharma Intl Drug List
Given below is the complete list of Strides Pharma Intl's drugs and the patents protecting them.
1. Accolate
Accolate is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5612367 | Method of enhancing bioavailability of pharmaceutical agents |
18 Mar, 2014
(11 years ago)
| Expired |
| US5482963 | Pharmaceutical agents useful as leukotriene antagonists |
09 Jan, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Accolate's drug page